196 related articles for article (PubMed ID: 12733726)
21. Intravenous aminopropylidene bisphosphonate (APD) in the treatment of Paget's bone disease.
Vega E; Gonzalez D; Ghiringhelli G; Mautalen C
J Bone Miner Res; 1987 Aug; 2(4):267-71. PubMed ID: 3455613
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of Paget's disease with olpadronate. Its efficacy in partial responders to oral pamidronate].
González D; Pastrana M; Mautalen C
Medicina (B Aires); 1997; 57 Suppl 1():25-31. PubMed ID: 9567351
[TBL] [Abstract][Full Text] [Related]
23. Biochemical assessment of Paget's disease of bone.
Shankar S; Hosking DJ
J Bone Miner Res; 2006 Dec; 21 Suppl 2():P22-7. PubMed ID: 17229003
[TBL] [Abstract][Full Text] [Related]
24. Serum OPG and RANKL levels before and after intravenous bisphosphonate treatment in Paget's disease of bone.
Martini G; Gennari L; Merlotti D; Salvadori S; Franci MB; Campagna S; Avanzati A; De Paola V; Valleggi F; Nuti R
Bone; 2007 Feb; 40(2):457-63. PubMed ID: 16979395
[TBL] [Abstract][Full Text] [Related]
25. Case report of implant placement in a patient with Paget's disease on bisphosphonate therapy.
Pirih FQ; Zablotsky M; Cordell K; McCauley LK
J Mich Dent Assoc; 2009 May; 91(5):38-43. PubMed ID: 19537656
[TBL] [Abstract][Full Text] [Related]
26. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
Alexandersen P; Peris P; Guañabens N; Byrjalsen I; Alvarez L; Solberg H; Cloos PA
J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
[TBL] [Abstract][Full Text] [Related]
27. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
Papapoulos SE; Frölich M
J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-6 and the acute phase response during treatment of patients with Paget's disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate.
Schweitzer DH; Oostendorp-van de Ruit M; Van der Pluijm G; Löwik CW; Papapoulos SE
J Bone Miner Res; 1995 Jun; 10(6):956-62. PubMed ID: 7572320
[TBL] [Abstract][Full Text] [Related]
29. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
Ringe JD; Reginster JY; Gennari C; Hosking DJ; Meunier PJ
Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
[TBL] [Abstract][Full Text] [Related]
30. Neridronic acid for the treatment of bone metabolic diseases.
Gatti D; Viapiana O; Idolazzi L; Fracassi E; Adami S
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1305-11. PubMed ID: 19761412
[TBL] [Abstract][Full Text] [Related]
31. Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone.
Merlotti D; Gennari L; Martini G; Valleggi F; De Paola V; Avanzati A; Nuti R
J Bone Miner Res; 2007 Oct; 22(10):1510-7. PubMed ID: 17605632
[TBL] [Abstract][Full Text] [Related]
32. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis.
Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH
Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791
[TBL] [Abstract][Full Text] [Related]
33. Treatment of Paget's disease of bone: a survey of clinical practice in Australia.
Walsh JP; Attewell R; Stuckey BG; Hooper MJ; Wark JD; Fletcher S; Ferrari V; Eisman JA
Bone; 2008 Jun; 42(6):1219-25. PubMed ID: 18353737
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological therapy of Paget's and other metabolic bone diseases.
Hosking D
Bone; 2006 Feb; 38(2 Suppl 2):S3-7. PubMed ID: 16406763
[TBL] [Abstract][Full Text] [Related]
35. Bisphosphonate resistance in Paget's disease of bone.
Joshua F; Epstein M; Major G
Arthritis Rheum; 2003 Aug; 48(8):2321-3. PubMed ID: 12905487
[TBL] [Abstract][Full Text] [Related]
36. The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.
Naylor KE; Jackson B; Eastell R
J Bone Miner Res; 2003 Apr; 18(4):658-61. PubMed ID: 12674326
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and treatment of Paget's disease of bone : A clinical practice guideline.
Muschitz C; Feichtinger X; Haschka J; Kocijan R
Wien Med Wochenschr; 2017 Feb; 167(1-2):18-24. PubMed ID: 27600563
[TBL] [Abstract][Full Text] [Related]
38. Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment.
Polyzos SA; Anastasilakis AD; Makras P; Terpos E
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):519-24. PubMed ID: 21811962
[TBL] [Abstract][Full Text] [Related]
39. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone.
Reid IR; Davidson JS; Wattie D; Wu F; Lucas J; Gamble GD; Rutland MD; Cundy T
Bone; 2004 Jul; 35(1):224-30. PubMed ID: 15207761
[TBL] [Abstract][Full Text] [Related]
40. Pharmacotherapy of Paget's disease of bone.
Reid IR
Expert Opin Pharmacother; 2012 Apr; 13(5):637-46. PubMed ID: 22339140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
